At present, the use of NAMs in regulatory submissions to the European Medicines Agency (EMA) is limited. This is owing to barriers such as developers' caution in sharing NAM data with regulators ...

The European Medicines Agency (EMA) gave its approval to an artificial intelligence diagnostic tool for the first time on ...

An exterior view of the European Medicines Agency, EMA, in Amsterdam's business district, Netherlands, on 20 April 2021.

Panalgo is also opening an office in Amsterdam, the home of the EMA, in order to provide close support for the roll-out and management of the new software at the regulator. Panalgo says IHD’s ...

We're expecting renewed growth for Dutch manufacturing in 2025 following a very weak couple of years. Growth remains moderate, but a turnaround is set to end the sector's two-year decline A sobering ...

The EMA is implementing major changes to accelerate ... in London and reduce its services whilst navigating the move to Amsterdam. By 2019, the agency had begun operating from its new home ...

Ionis Pharmaceuticals, Inc. today announced that it has entered into a license agreement under which Sobi® receives exclusive rights in countries outside the U.S., Canada and China to commercialize ...

The EU lacks cohesive governance to deploy economic statecraft tools, such as sanctions and export controls, undermining ...

Medicenna Therapeutics Corp. ("Medicenna" or the "Company") , a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer and autoimmune diseases, announced today ...

uniQure was founded in 1998 as Amsterdam Molecular Therapeutics and ... which was approved by the FDA in November 2022 and by the EMA and Health Canada in 2023. It was officially out-licensed ...